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INTRODUCTION
SARS- CoV-2 is a highly infectious RNA virus which 
predominantly causes infection of the nasopharynx and 
upper respiratory tract. It is a novel human pathogen and, 
accordingly, one where no previous immunity has been 
encountered in the human population. It is currently 
causing an international pandemic, with over 6 million 
cases globally at the beginning of June and continued new 
infections. Severe infection has significant mortality, with a 
reported 614 deaths per 1 million population in the United 
Kingdom1 to date. Whilst predominantly a respiratory, 
infectious disease and critical care pathology, COVID-19 
infection and its sequelae has influenced the care of the 
unvetted General Surgical Emergency admission. This 
is particularly germane when mortality and pulmonary 
complications in patients undergoing surgery with COVID 
infection has an associated mortality rate of 24%.2
https:// doi. org/ 10. 1259/ bjro. 20200044
Objective: The SARS- CoV2 infection is associated with 
high mortality for individuals who undergo emergency 
surgery. The United Kingdom surgical associations and 
Colleges of Surgeons collectively recommended the 
addition of CT Thorax to all emergency CT abdomen/
pelvis imaging in order to help identify possible COVID-19 
patients. Early identification of these patients would 
lead to optimal treatment strategies for the patient and 
protection for staff members. However, an extension of 
CT would be associated with increased irradiation doses 
for the patient, and its diagnostic relevance was unclear.
Methods: This was a retrospective observational review 
looking at all surgical admissions that required a CT 
Thorax/Abdomen/Pelvis across 7 weeks during the 
COVID-19 pandemic, across four Scottish Hospitals. CT 
thorax investigations (of non- surgical patients) were 
also re- assessed by a single radiologist to assess the 
extent of pathology identified at the lung bases (and 
therefore would be included in a standard CT abdomen 
and pelvis).
Results: Of 216 patients identified who had a CT thorax/
Abdomen/Pelvis during the timeframe, 5 were diag-
nosed with COVID-19. During this timeframe, 77 patients 
underwent solely CT thorax. Across the entire cohort, 
98% of COVID pathology was identified at the lung 
bases. The estimated sensitivity and specificity of CT 
thorax was 60 and 86.4% respectively.
Conclusions: In a region with relatively low prevalence of 
SARS- COV2 infection, inclusion of CT Thorax in surgical 
admission imaging does not significantly contribute to 
identification and management of SARS- COV2 patients. 
We therefore suggest that imaging the lung bases can 
be sufficient to raise clinical suspicion of COVID-19.
Advances in knowledge: This paper adds further 
evidence to that from other single UK centres that the 
addition of CT chest for all patients does not yield any 
further diagnostic information regarding coronavirus. 
Additionally, rapid SARS- CoV-2 testing in the UK (which 
is currently widely available) further demonstrates that 
inclusion of the entire chest during CT examination of 
the acute abdomen is not required.
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The COVID-19 pandemic has resulted in significant changes 
to admission pathways within the acute setting. Both general 
medical and surgical pathways in most hospitals have COVID-19 
assessment units and treatment wards. Patients without 
COVID-19 are managed in separate areas of the hospital, where 
possible. Guidance for management of patients with suspected 
COVID-19 have thus focused on early identification of individ-
uals at risk of COVID-19. This aimed to optimise patient and 
staff safety. Patients who have COVID-19 are higher mortality 
rates individually, but also can lead to the infection of other 
patients and staff members alike. Furthermore, patients who may 
require theatre will be subject to aerosol generating procedures 
and may lead to further post- operative deterioration associated 
with this disease.
In the United Kingdom, an intercollegiate agreement was made 
between several surgical colleges and associations,3 which made 
several recommendations. Specifically relating to acute admis-
sions, the guidance states: “Any patient undergoing an abdom-
inal CT scan for acute pain as an emergency presentation should 
have a CT chest at the same time, unless CT chest previously 
performed within 24 h. Current tests for COVID-19, including 
CXR and chest CT, may be false negative.” The inclusion of 
CT chest may contribute to the early recognition of patients 
with COVID-19, and thus optimise clinical care during the 
pandemic.4,5 As the pandemic has developed, the British Society 
of Thoracic Imaging (BSTI) and Royal College of Radiologists 
(RCR) have recommended against the usage of CT chest in the 
acute surgical patient.6,7 However, the Royal Colleges of Surgeons 
have yet to change their guidance where CT thorax is still recom-
mended in this setting.
Such an approach involves a significant increase in radiation 
exposure for patients, as well as additional workload for the 
radiologist. Given the increased cancer risk through exposure 
to ionising radiation, coupled with CT chest being normal in 
COVID settings in up to 20% of cases,8 means that the potential 
risks of additional imaging may outweigh the clinical gain.
Additionally, approximately 4% of patients with COVID-19 
infection present solely with gastrointestinal symptoms, with all 
others reporting some form of upper respiratory symptom that 
can be identified through focused history at presentation.9 Lung 
bases are included in abdominal imaging and can be sufficient 
for identification of COVID-19.10 As such, through a combina-
tion of increased radiation exposure alongside minimal clinical 
gain, the routine inclusion of CT chest in patients presenting 
with abdominal pain during the pandemic has been brought into 
question. We therefore aimed to look at the clinical significance 




This was a multicentre retrospective observational cohort study.
Study setting
All patients presenting to emergency general surgery in four 
hospitals in the north of Scotland were included. Aberdeen Royal 
Infirmary is a tertiary referral centre in the North East of Scotland 
caring for a population of 580,000 patients. Dr Gray’s Hospital 
is a district general hospital in Elgin caring for 95,000 individ-
uals. Balfour Hospital in Orkney and the Gilbert Bain Hospital 
in Shetland are the main hospitals managing patients in both of 
these Island sets. The approximate population managed by these 
island hospitals is 45,000. We assume a disease prevalence of 5%. 
This is based on cumulative data collected during the pandemic 
relating to tests performed and proportion of positive results.11
Patients
All acute adult (aged >16) surgical presentations undergoing 
CT Chest/Abdomen/Pelvis (CT CAP) during their admission 
between 25 March 2020 and 12 May 2020 were included. Patients 
were identified through the common server by searching for all 
CAP scans undertaken during the study period (PACS). CT 
CAP scans were excluded from analysis if undertaken due to 
trauma, elective investigation of surgical pathology and investi-
gation of non- surgical pathology (e.g. staging scans for cancer). 
CT technique used on all CT scanners within the study centres 
consisted of intravenous iodinated contrast spiral volume 
acquisition through the whole chest, abdomen, and pelvis. CT 
reports were reviewed for evidence of SARS- CoV-2. A score 
for diagnoses of SARS- CoV-2 was then allocated to each indi-
vidual CT scan based on guidance from the BSTI. The scoring 
system identified scans as normal findings (CVCT0), typical/
classic SARS- CoV-2 pathology (CVCT1), indeterminate find-
ings which may be in keeping with SARS- CoV-2 (CVCT2), and 
non- COVID-19 pathology (CVCT3).12 CT findings were then 
correlated with results of SARS- CoV-2 throat/nasal swab. These 
data, and data on patient outcome, management and operative 
interventions were obtained from the electronic patient record 
(EPR Trackcare).
Assessment of CT findings
Scans were re- assessed by a chest radiologist with particular 
attention to whether SARS- CoV-2 CT changes were evident 
in the lung bases, as this area of the chest would be routinely 
included in abdominal imaging. A second data set was also 
collected on all patients across the above sites that had CT 
imaging of the chest regardless of presentation or suspicion of 
COVID-19. These data were collected in the same time period 
of 7 weeks across the same hospitals used in the CT CAP cohort. 
These patients were again allocated a COVID score, with find-
ings correlated with swab status. This second set was collected 
to better appreciate the proportion of known SARS- CoV-2 posi-
tive patients who may have had CT changes, and whether those 
changes were visible in the lung bases.
Data analysis
Data were stored on password secured NHS computers on excel 
spreadsheet. Specificity and sensitivity analysis was performed 
using an online calculator ( MedCalc. com)
Ethical review
This retrospective study and audit of clinical practice has been 
registered with the NHS Grampian clinical effectiveness team.
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RESULTS
A total of 212 patients had a CT chest/abdomen and pelvis test 
during the study timeframe and were included in the study. 
There were only three cases in this cohort (the surgical cohort) 
where CT findings were in keeping with SARS- CoV-2, an 
example can be seen in Figure 1, demonstrating typical features 
of peripheral, mostly basal, ground glass opacities and foci of 
consolidation. The number patients with indeterminate find-
ings was nine. Thus, 210 patients (95%) had a CT scan of their 
chest with no findings of SARS- CoV-2. The demographics of 
the cohort are depicted in Table 1.
As the number of positive patients in this cohort was low (5%), 
any further analysis of the diagnostic accuracy of a CT scan in 
this context was not possible assessing these patients individu-
ally. Accordingly, a further analysis was performed on patients 
who had a positive diagnosis of SARS- CoV-2 on CT chest 
undertaken during the same timeframe in the same hospi-
tals (the non- surgical cohort). These patients had no clinical 
suspicion of surgical pathology, were managed in separate 
areas of the hospitals and did not have a CT of their abdomen 
or pelvis. There was a total of 77 patients in this cohort. The 
demographics of this group are depicted in Table 2.
Those cases where there were findings identified on CT chest 
were then re- analysed by a chest radiologist to assess whether 
the lung pathology could be identified at the lung bases 
(thereby being identifiable on a standard portal venous phase 
protocol CT abdomen and pelvis). A total of 98% of the find-
ings in both cohorts could be identified at the lung bases. The 
individual patient in the surgical cohort where the findings 
were above this level tested negative by swab and the indeter-
minate findings on their scan were approximately 5 cm above 
the diaphragm. This data is represented in Table 3.
DISCUSSION
Ever since the 2019 Novel Coronavirus, SARS- CoV2 (or 
COVID19), was identified as a human pathogen in Wuhan 
Provence in China,13 early identification of those with the 
disease has been of paramount importance.14 Individuals diag-
nosed with SARS- CoV2 infection can be cared for with the 
appropriate precautions to reduce risk of nosocomial spread. 
As such, adding a CT chest to anyone who is requiring a CT 
assessment of the abdominal and pelvic organs was suggested 
by national bodies in the United Kingdom.3 However, 
within this early snapshot review, in a population where the 
Figure 1. Contrast- enhanced CT of the chest through the lung 
bases demonstrating bibasal foci of ground glass opacifica-
tion, mostly in the peripheries, in keeping with SARS- CoV-2 
infection.
Table 1. Demographics of surgical cohort who had a CT Chest/
Abdomen and Pelvis examination as an emergency in the 
timeframe during this study
CT Chest/Abdomen/
Pelvis




Aberdeen Royal Infirmary 190
Dr Grays 16
Gilbert Bain (Shetlands) 5
Balfour (Orkneys) 1
CT Chest findings
Normal Chest findings (106)50%
Indeterminate findings (9)4%
Positive findings (3)1%











Renal Calculi 6 (3%)
Ileus 5 (2.5%)
Post- operative collection 3 (1.5%)
Sigmoid volvulus 2 (1%)
Bowel Ischaemia 2 (1%)
Other 17 (8%)
IQR, interquartile range.
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prevalence of SARS- CoV2 is comparatively low, our data 
would suggest that such a practice adds little in the manage-
ment of this pandemic. This is particularly pertinent now, we 
see the rates reducing across the western world and easier 
access to RT- PCR swab testing. Our analysis of sensitivity and 
specificity is represented in Table 4.
The symptoms experienced by a patient who has contracted 
the virus varies greatly. Although the majority are respiratory 
or coryzal (cough, shortness of breath, loss of smell and taste) 
abdominal and gastrointestinal symptoms are recognised in 
up to 20% of cases.15 However, only a minority (approximately 
4%) will have isolated abdominal symptoms.10 In the case of 
those with suspected surgical pathology, careful history taking, 
and examination is required to further stratify the possibility 
of COVID-19 as a cause for the presentation. With appro-
priate clinical acumen, patients who have had close contacts 
with SARS- CoV2 or upper respiratory tract symptoms can be 
identified, A CT chest could be considered for these individ-
uals. However, given that the majority (98%) of lung pathology 
identified in this study was noted in the lung bases, missed 
cases of SARS- CoV2 infection is unlikely when a CT of the 
upper abdomen (which will inevitably include lung bases) is 
performed.
We have identified a similar study being performed during 
this time- period. This is a study performed in Southampton, 
which comes to a similar conclusion regarding the inclusion 
of CT thorax.16 However, the main the difference is our inclu-
sion of CT thorax reviews to clarify lung base findings, and our 
regional change in guidance as a result. This is a dynamic field 
of research,17,18 and other studies have assessed the diagnostic 
pick up of pathology at the lung bases and confirm our find-
ings of identification of pathology at these sites.19–21 However, 
we have analysed the safety of excluding the formal CT scan 
of the thorax, as a screening tool, in patients who present 
with abdominal pain in a region of presumed low COVID 19 
prevalence.
Interestingly, during the initial discussions about re- estab-
lishing elective practice, patient self- isolation, testing by RT 
PCR and CT chest were all suggested to be required before 
it was safe to undertake a general anaesthetic. Given the 
high mortality rate associated with post- operative COVID 
19 infection, this was an understandably stringent precau-
tion. However, CT chest is no longer deemed necessary in the 
elective setting.22 The guidance has yet to be changed for the 
emergency surgical patients and our data would suggest that 
reducing the rates of CT chests performed in this cohort is 
appropriate.
Our review has several limitations. There have been little data 
published around the disease prevalence of COVID-19. We 
have presumed a prevalence of less than 10%, however, there 
are little data to support the proportion of infected patients. 
The number of patients swabbed and tested by RTPCR varied 
during the length of this study. Swabs increased when avail-
ability allowed. However, a true assessment of accuracy 
between CT and RT PCR is not possible in this work. It is also 
a retrospective study. Patient capture was however from the 
regional radiology network, Picture Archiving and Communi-
cations System (PACS). As such, it is unlikely that any patients 
will be missed from our analysis. Our surgical admission data 
were limited in its representation of patients with COVID-
19. Only 5 patients out of a possible 216 were identified as 
having the disease, which gives a limited representation of 
the overall prevalence of COVID-19 within the community. 
It does however emphasise the small proportion of concurrent 
surgical problems with COVID-19 as acute presentations. In 
order to better appreciate the diagnostic significance of CT 
chest, the second data set was collected which strengthens this 
study significantly. This data set represented CT chest imaging 
Table 2. Demographic characteristics of patients who had a 
CT chest and were found to have SARS- CoV-2 infection
CT Chest
Median age (IQR) 65 (21)
% FEMALE (31)40%
% MALE (46)60%





Table 3. shows the assessment of lung base pathology
CT Chest/Abdomen/
Pelvis CT chest
Total cases 212 77
Cases with CT 
changes
88 77
Changes visible in 
lung bases (%)
98% (87) 98% (76)
Table 4. shows the predicted sensitivity and specificity of 
CT chest, compared to RT- PCR swab testing in the surgical 
cohort (n = 88). This assumes a prevalence of 5% during this 
timeframe









RT PCR, reverse transcription polymerase chain reaction.
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in those with high clinical suspicion of COVID-19, regardless 
of pathology.
The addition of chest imaging to acute surgical admission 
imaging has not significantly contributed to the identifica-
tion of patients with COVID-19. These data have changed 
regional practice in that we no longer include the chest 
imaging, unless there is a high clinical suspicion, or if on 
review the lung bases are suggestive of COVID-19. Given the 
dynamic nature of this pandemic, and the resource strain, we 
feel that this is safe for patients, reduces radiation and has a 
low false negative rate.
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